New Diabetes Combo Approved

Share this content:
New Diabetes Combo Approved
New Diabetes Combo Approved
A once-daily, extended-release formulation that combines dapagliflozin and metformin (Xigduo XR) has been approved for the treatment of type 2 diabetes in adults, announced manufacturer AstraZeneca. It will be available in several dosage strengths of dapagliflozin and metformin, including 5 mg/500 mg, 5 mg/1,000 mg, 10 mg/500 mg, and 10 mg/1,000 mg.
READ FULL ARTICLE From Medical Page Today
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »